Barry L. Templin - 16 Apr 2026 Form 3 Insider Report for PROCEPT BioRobotics Corp (PRCT)

Reporting relationship: EVP, Chief Technology Officer
Issuer ticker: PRCT
Reported as of: 16 Apr 2026
Net transaction value: $0
SEC form: 3
Accepted by SEC: 30 Apr 2026, 17:30:42 UTC
Next SEC filing: 10 Jun 2026
Source filing: View source filing
Reporting owner signature: /s/ Jonathan Stone, Attorney-in-Fact for Barry Templin

Key filing fact

Barry L. Templin filed Form 3 for PROCEPT BioRobotics Corp (PRCT) on 30 Apr 2026.

Key facts

This page summarizes Barry L. Templin's Form 3 filing for PROCEPT BioRobotics Corp (PRCT).
0 reported transactions and 7 derivative rows are listed below.
Accepted by SEC: 30 Apr 2026, 17:30.

Change

No earlier filing in this sequence is available for direct comparison.
Current net transaction value: $0.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Official SEC source

Ownership activity is grounded in SEC Form 3 disclosures.

View source filing

Reporting Owners (1)

CIK 0002132820 Primary reporting owner

Templin Barry L

Relationship: EVP, Chief Technology Officer
Address: 150 BAYTECH DR., SAN JOSE
Signature: /s/ Jonathan Stone, Attorney-in-Fact for Barry Templin
Signature date: 30 Apr 2026

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

PRCT holding

Common Stock

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after: 69,311
Date: 16 Apr 2026
Ownership: Direct
Footnotes: F1

PRCT holding

Common Stock

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after: 56,457
Date: 16 Apr 2026
Ownership: Barry L Templin and Katrina L. Templin, Trustees of the Templin Trust dated February 3, 2020

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

PRCT holding Derivative

Stock Option (Right to Buy)

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
Date: 16 Apr 2026
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 34,591
Exercise price: $5.18
Footnotes: F2

PRCT holding Derivative

Stock Option (Right to Buy)

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
Date: 16 Apr 2026
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 19,999
Exercise price: $7.27
Footnotes: F2

PRCT holding Derivative

Stock Option (Right to Buy)

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
Date: 16 Apr 2026
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 19,982
Exercise price: $34.99
Footnotes: F2

PRCT holding Derivative

Stock Option (Right to Buy)

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
Date: 16 Apr 2026
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 26,253
Exercise price: $37.02
Footnotes: F3

PRCT holding Derivative

Stock Option (Right to Buy)

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
Date: 16 Apr 2026
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 16,835
Exercise price: $47.17
Footnotes: F4

PRCT holding Derivative

Stock Option (Right to Buy)

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
Date: 16 Apr 2026
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 14,388
Exercise price: $60.60
Footnotes: F5

PRCT holding Derivative

Stock Option (Right to Buy)

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
Date: 16 Apr 2026
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 29,615
Exercise price: $25.35
Footnotes: F6

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 6 footnotes

Footnote F1

These securities include restricted stock units (RSUs). Each RSU represents a contingent right to receive one share of Common Stock. One-quarter of the RSUs shall vest on the anniversary of the grant date, with one-twelfth of the remaining RSUs shall vest on each quarter thereafter, subject to the Reporting Person continuing as a service provider through such date.

Footnote F2

The Stock Option is fully vested and exercisable.

Footnote F3

The Stock Option was granted on 2/16/2023, and 1/48th of the shares subject to the Stock Option shall vest monthly from the vesting commencement date of March 5, 2023, over a four year period, subject continued employment or service by the Reporting Person to the Issuer through the applicable vesting date

Footnote F4

The Stock Option was granted on March 6, 2024 and 1/48th of the shares subject to the Stock Option shall vest monthly from the vesting commencement date of March 5, 2024, over a four year period, subject continued employment or service by the Reporting Person to the Issuer through the applicable vesting date

Footnote F5

The Stock Option was granted on March 3, 2025, and 1/48th of the shares subject to the Stock Option shall vest monthly from the vesting commencement date of March 5, 2025, over a four year period, subject continued employment or service by the Reporting Person to the Issuer through the applicable vesting date

Footnote F6

The Stock Option was granted on March 5, 2026, and 1/48th of the shares subject to the Stock Option shall vest monthly from the vesting commencement date of March 5, 2026, over a four year period, subject continued employment or service by the Reporting Person to the Issuer through the applicable vesting date

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. to update or revoke optional consent for future visits. For more information, see our Privacy Policy .